GlassScriptPhysician profile
Leena Sharan
NPI 1326006685
$71,414.89
in general payments reported to CMS, 2019-2025
54 companies · $1,937 in 2025
The $1,937 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $6,162 · 2021: $18K · 2022: $13K · 2023: $10K · 2024: $6,620 · 2025: $1,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $6,645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Food and Beverage | $6,645.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54,301.14 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $1,939.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $1,751.27 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,364.85 | 2019-2025 | |
| Amgen INC. | $1,229.71 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,193.99 | 2019-2025 | Mitraclip, Aveir, Xience Skypoint |
| Pfizer INC. | $1,027.45 | 2019-2025 | |
| Itamar Medical INC | $786.09 | 2021-2025 | Watchpatone |
| Merck Sharp & Dohme LLC | $724.37 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $696.73 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $622.05 | 2021-2025 | Symplicity G3 |
| Heartflow, INC. | $487.26 | 2019-2025 | Ffrct |
| Amarin Pharma, INC. | $456.68 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $450.14 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $429.96 | 2020-2024 | Nexletol |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $390.23 | 2019-2024 | Farxiga, Brilinta |
| Alnylam Pharmaceuticals INC. | $367.13 | 2021-2025 | Onpattro |
| Genzyme Corporation | $308.88 | 2019-2023 | |
| Medicure Pharma INC. | $275.02 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $231.73 | 2019-2024 | |
| Lundbeck LLC | $224.42 | 2019-2021 | |
| Astellas Pharma US INC | $212.16 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $153.38 | 2019-2025 | Evkeeza |
| Zoll Respicardia, INC. | $143.52 | 2023 | Remede System |
| Boston Scientific Corporation | $141.20 | 2025 | Avvigo Guidance System |
| Arbor Pharmaceuticals, INC. | $114.50 | 2019-2021 | |
| Philips North America LLC | $111.12 | 2024 | (R11) US Eq Undivided |
| Kiniksa Pharmaceuticals International, Plc | $110.54 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $102.47 | 2019-2021 | |
| Novo Nordisk INC | $88.98 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Bridgebio Pharma, INC. | $83.69 | 2025 | Attruby |
| Cleerly, INC. | $83.05 | 2024-2025 | Cleerly Labs, Cleerly Ischemia |
| Innovation Technologies INC | $73.62 | 2022-2023 | Irrisept |
| Baxter Healthcare | $71.39 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Terumo Medical Corporation | $71.03 | 2019 | |
| Cvrx, INC. | $57.44 | 2022-2023 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $56.94 | 2025 | |
| Althera Pharmaceuticals LLC | $51.89 | 2022 | |
| Scpharmaceuticals INC. | $51.16 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $48.37 | 2019-2021 | |
| Angiodynamics, INC. | $47.49 | 2022 | |
| Recor Medical INC | $38.62 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Inspire Medical Systems, INC. | $36.48 | 2024 | Inspire |
| Edwards Lifesciences Corporation | $30.83 | 2019-2022 | |
| G Medical Diagnostic Services, INC. | $29.00 | 2022-2023 | Cardiac Monitoring Suite |
| Lexicon Pharmaceuticals, INC. | $23.07 | 2023 | Inpefa |
| Atricure, INC. | $19.93 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $16.79 | 2023 | Arcalyst |
| Cashflow Solutions, LLC | $15.80 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Glaxosmithkline, LLC. | $15.57 | 2025 | Arexvy |
| Zoll Circulation INC | $14.92 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Surmodics, INC. | $14.12 | 2024 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Bardy Diagnostics, INC. | $14.00 | 2021 | |
| Intact Vascular, INC. | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leena Sharan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.